PRA Health Sciences Accounts Payable

PRA Health Sciences's accounts payable stands at $46M as of March 2021. That compares with $58M in the prior-year period — down 19.5% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

PRA Health Sciences reported $46M in accounts payable versus $58M a year earlier — a 19.5% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $58M in the prior-year period — down 19.5% year over year. Sustained growth in accounts payable can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how PRA Health Sciences's accounts payable evolved across reporting periods, while the comparison chart places PRAH next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, accounts payable is commonly used to spot outliers. PRA Health Sciences's reading of $46M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.